Immune-modulatory effects of Spindlin-1 inhibitors., PMID:40512144
An Auxin Inducible Degradation System to Study Mklp2 Functions in MDCK Epithelial Cells., PMID:40490973
A novel pThr217 tau monoclonal antibody reveals neuropathological heterogeneity in tauopathies., PMID:40473739
Synaptotoxic effects of extracellular tau are mediated by its microtubule-binding region., PMID:40455293
Hippocampal subfields: volume, neuropathological vulnerability and cognitive decline in Alzheimer's and Parkinson's disease., PMID:40448161
Chimeric antigen receptors discriminate between tau and distinct amyloid-beta species., PMID:40448101
Acute targeting of N-terminal tau protein has long-lasting beneficial effects in Tg2576 APP/Aβ mouse model by reducing cognitive impairment, cerebral Aβ-amyloidosis, synaptic remodeling and microgliosis later in life., PMID:40442822
Insights into pathophysiology, biomarkers, and therapeutics in tauopathies: Proceedings of the Tau2024 Global Conference., PMID:40437880
Immunotherapy against tau fragment diminishes AD pathology, improving synaptic function and cognition., PMID:40426267
[Prospects for treating Alzheimer's disease]., PMID:40420451
Investigating Anti-Tumor Effects of Irisin in Cervical Cancer Cells: Cell Viability, Migration, and Tumor-Associated Macrophage Polarization., PMID:40415369
Intracerebroventricular phospho-tau immunotherapy alleviates cortical phospho-tau burden and motor phenotype in a neuron-specific P301S tauopathy mouse., PMID:40403829
The role of autophagy in ischemic brain injury., PMID:40395988
Anti-cis P-tau attenuates tauopathy and enhances cognitive function following global cerebral ischemia in mice., PMID:40378437
Development of Zn-Based Tower-like Photoelectrochemical Sensor Array for Sandwich-Type Immunosensing Analysis of Tau., PMID:40374565
Dynamics of IgM and IgA Antibody Response Profile Against Vibrio cholerae Toxins A, B, and P., PMID:40331989
Targeted proteomic biomarker profiling using NULISA in a cohort enriched with risk for Alzheimer's disease and related dementias., PMID:40318118
A Novel Phosphorylated Tau Conformer Implicated in the Tauopathy Pathogenesis of Human Neurons., PMID:40305319
Facile generation of drug-like conformational antibodies specific for amyloid fibrils., PMID:40301692
Yellow fever virus infection alters mitochondrial network dynamics and trigger IFN-I response via TLR2 pathway., PMID:40300356
Nanobody-based double antibody sandwich colloidal gold test strips for rapid detection of urinary biomarkers NMP22 and survivin in bladder cancer., PMID:40300312
Daily high doses of atorvastatin alter neuronal morphology in a juvenile songbird model., PMID:40294005
KIF26B promotes bladder cancer progression via activating Wnt/β-catenin signaling in a TRAF2-dependent pathway., PMID:40253697
Divergent disruptive effects of soluble recombinant tau assemblies on synaptic plasticity in vivo., PMID:40251677
Small-Molecule Mitotic Inhibitors as Anticancer Agents: Discovery, Classification, Mechanisms of Action, and Clinical Trials., PMID:40244152
Colorectal cancer stem cells develop NK cell resistance via homotypic cell-in-cell structures suppressed by Stathmin1., PMID:40225568
Inhibition of tau neuronal internalization using anti-tau single domain antibodies., PMID:40175345
Enhancing anti-CD3 mAb-mediated diabetes remission in autoimmune diabetes through regulation of dynamin-related protein 1(Drp1)-mediated mitochondrial dynamics in exhausted CD8+T-cell subpopulations., PMID:40165248
Targeting of phosphorylated tau at threonine 181 by a Qβ virus-like particle vaccine is safe, highly immunogenic, and reduces disease severity in mice and rhesus macaques., PMID:40145301
Competitive electrochemical immunosensor for trace phosphorylated Tau181 analysis in plasma: Toward point-of-care technologies of Alzheimer's disease., PMID:40139011
Investigation of the HLA locus in autopsy-confirmed progressive supranuclear palsy., PMID:40132252
Influence of apolipoprotein E genotype on the proteomic profile in cerebral microdialysis after human severe traumatic brain injury: a prospective observational study., PMID:40109561
Clinical significance of "S" isoform of DCLK1 in different gastric cancer subtypes using newly produced monoclonal antibody., PMID:40109216
Association of dietary fatty acids with longitudinal change in plasma-based biomarkers of Alzheimer's disease., PMID:40107919
Shear stress preconditioning enhances periodontal ligament stem cell survival., PMID:40086040
DCLK1 in gastrointestinal cancer: A driver of tumor progression and a promising therapeutic target., PMID:40056091
Overlapping presence of β-amyloid, tau, p-tau, and α-synuclein in skin nerve fibers in Alzheimer's disease., PMID:40042672
Renal Expression Levels of C5a Receptor and Autophagy-related Beclin-1 and LC3A/B Are Simultaneously Enhanced Under Immunoglobulin Treatment in a Rat Model of Sepsis., PMID:40010959
18F-MK-6240 tau PET in patients at-risk for chronic traumatic encephalopathy., PMID:39994806
Eligibility for donanemab trial in a population-based study of cognitive aging., PMID:39966022
Associations of Cerebrospinal Fluid Orexin-A, Alzheimer Disease Biomarkers, and Cognitive Performance., PMID:39957622
Melanocortin 3 receptor regulates hepatic autophagy and systemic adiposity., PMID:39956805
Biofluid biomarker changes following treatment with sabirnetug (ACU193) in INTERCEPT-AD, a phase 1 trial in early Alzheimer's disease., PMID:39955261
Multimer Detection System: A Universal Assay System for Differentiating Protein Oligomers from Monomers., PMID:39940966
Phospho-tau serine-262 and serine-356 as biomarkers of pre-tangle soluble tau assemblies in Alzheimer's disease., PMID:39930142
The impact of apolipoprotein E, type ∊4 allele on Alzheimer's disease pathological biomarkers: a comprehensive post-mortem pilot-analysis., PMID:39913635
Clinical trials targeting tau should be halted., PMID:39908690
The value of CSF diagnostic and prognostic biomarkers in NMOSD and MOGAD in real-life use., PMID:39893752
Biomarker treatment effects in two phase 3 trials of gantenerumab., PMID:39887500
Modeling Sporadic Progressive Supranuclear Palsy in 3D Midbrain Organoids: Recapitulating Disease Features for In Vitro Diagnosis and Drug Discovery., PMID:39876539
For research use only. Not for human or drug use.
